{"schema_version":"secwatch.filing_event.v1","accession":"0001217234-24-000062","form_type":"8-K","ticker":"CDNA","cik":"0001217234","company_name":"CareDx, Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.589957+00:00","generated_at":"2026-06-02T04:59:01.671946+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CareDx Q1 revenue $72M (-7% YoY); raises FY2024 revenue guidance to $274-282M","bullets":["Revenue $72.0M, down 7% YoY from $77.3M but up 10% sequentially from Q4 2023.","Net loss $16.7M ($0.32 loss per share) improved from $23.7M loss ($0.44) a year ago.","Testing Services revenue $53.8M, down 13% YoY but up 15% sequentially; patient results ~42,000, up 6% sequentially.","Adjusted EBITDA loss $1.9M vs $6.4M loss in Q1 2023 and $10.3M loss in Q4 2023.","Raises FY2024 revenue guidance to $274-282M; cash $216M with no debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001217234-24-000062","json":"https://secwatch.observer/filing/0001217234-24-000062.json","markdown":"https://secwatch.observer/filing/0001217234-24-000062.md","text":"https://secwatch.observer/filing/0001217234-24-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1217234/000121723424000062/0001217234-24-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1217234/000121723424000062/cdna-20240509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T04:59:01.671946+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e8b5f7e7b50e732c16bdc4e8d84713cc02b07b5","claim":"CareDx, Inc. reported the first quarter ended March 31, 2024 results: revenue $72.0 million, net income net loss was $16.7 million, EPS $0.32. Guidance raised.","evidence_excerpt":"CareDx, Inc. (Nasdaq: CDNA) — today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights • Reported first quarter revenue of $72.0 million. • Revenue for Testing Services of $53.8 million, an increase of 15% as compared to the fourth quarter 2023. • Grew testing services patients results for the third consecutive","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1217234/000121723424000062/0001217234-24-000062-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Revenue","value":"$72.0 million"},{"label":"Net income","value":"net loss was $16.7 million"},{"label":"EPS","value":"$0.32"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}